No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Medical - Devices
Beijing Leadman Biochemistry Co.,Ltd. is a prominent entity within the People's Republic of China, specializing in the entire lifecycle – from research and development to manufacturing and distribution – of advanced in vitro diagnostic (IVD) solutions. Its product portfolio encompasses a comprehensive range of biochemical raw materials. This includes critical components like enzymes, coenzymes, antibodies, various buffers, enzyme substrates, culture media, staining reagents, and amino acids. These essential ingredients serve a diverse array of sectors, notably biotechnology, clinical diagnostics, pharmaceutical development, and chemical manufacturing. Beyond raw materials, Leadman also provides specialized biochemistry diagnostic and complementary reagents. Furthermore, the company supplies a sophisticated selection of medical instrumentation. This lineup features the EnigmaML, an automated molecular testing platform designed for both clinical laboratories and various point-of-care settings like clinics and pharmacies. Another key offering is the DiaSys InnovaStar, a compact automated POCT analyzer that delivers laboratory-grade diagnostic accuracy. Customers also benefit from the DiaSys Respons, a versatile random access benchtop analyzer; the CI1000 automatic chemiluminescence immunoassay analyzers; and the IDS-isys, an instrument engineered to boost operational performance and efficiency. Established in 1997, Beijing Leadman Biochemistry maintains its corporate headquarters in Beijing, China.
www.leadmanbio.comNo one on the platform currently holds 300289.SZ.
No tracked institution reports a position in 300289.SZ as of their last filing.
No one on the platform has traded 300289.SZ yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Analyst estimates unavailable for this ticker.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| 300289.SZBeijing Leadman Biochemistry Co.,Ltd. | $5.66 | +0.18% | $3.1B | — |
| 002022.SZShanghai Kehua Bio-engineering Co., Ltd. | $5.55 | +0.00% | $2.9B | — |
| 002462.SZCachet Pharmaceutical Co., Ltd. | $12.05 | -0.25% | $3.5B | — |
| 002932.SZWuhan Easy Diagnosis Biomedicine Co.,Ltd. | $15.24 | -0.39% | $3.5B | — |
| 300314.SZNingbo David Medical Device Co., Ltd. | $11.56 | +3.40% | $3.3B | — |
| 300318.SZBeijing Bohui Innovation Biotechnology Group Co., Ltd. | $4.79 | +0.42% | $3.9B | — |
| 300326.SZShanghai Kinetic Medical Co., Ltd | $6.08 | +0.83% | $4.4B | — |
Source: Financial Modeling Prep · peers by sector/industry